NASDAQ: CTCXCarmell Corp Stock
$3.15+0.16 (+5.35%)
Updated Dec 7, 2023
CTCX Price
$3.15
Fair Value Price
N/A
Market Cap
$72.71M
52 Week Low
$1.70
52 Week High
$13.31
P/E
N/A
P/B
3.48x
P/S
2.62x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.65M
Earnings
-$18.67M
Gross Margin
89.9%
Operating Margin
-63.72%
Profit Margin
-75.1%
Debt to Equity
2.93
Operating Cash Flow
-$8M
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CTCX Overview
Alpha Healthcare Acquisition Corp. III is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar combinations with one or more businesses. Ittargets the healthcare sector in the U.S. The company was incorporated in 2021 and is based in New York, NY.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CTCX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CTCX is good value based on its book value relative to its share price (3.48x), compared to the US Biotechnology industry average (5.45x)
P/B vs Industry Valuation
CTCX's cash and short-term investments ($7.97M) cannot cover CTCX's cash burn for the next year ($8.37M), once increasing cash burn (N/A) is accounted for
Interest Coverage Financials
CTCX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
There are 30 more CTCX due diligence checks available for Premium users.
Be the first to know about important CTCX news, forecast changes, insider trades & much more!
CTCX News
Valuation
CTCX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
11.53x
Market
31.17x
CTCX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.48x
Industry
5.45x
CTCX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CTCX's financial health
Profit margin
Revenue
$3.7M
Net Income
-$11.5M
Profit Margin
-308.8%
CTCX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CTCX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$82.2M
Liabilities
$61.3M
Debt to equity
2.93
CTCX's short-term assets ($38.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTCX's short-term assets ($38.87M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTCX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.5M
Investing
$636.2k
Financing
$12.4M
CTCX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CTCX vs Biotech Stocks
Carmell Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.